Handelsbanken Fonder’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

Handelsbanken Fonder’s Portfolio CNST Stock Details CNST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-9,900	Closed	-$335K	–	1707
2021 Q2	$335K	Buy	+9,900	New	+$252K	﹤0.01%	1597

Handelsbanken Fonder's CNST Position: Q3 2021 in Review

Handelsbanken Fonder sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q3 2021, closing a stake of 9,900 shares — an estimated $335K sold.

Handelsbanken Fonder first reported a position in CNST in Q2 2021 and held it in 1 quarter. The position peaked at $335K in Q2 2021. 0 funds tracked by Wall St. Rank hold CNST as of Q3 2021.

Handelsbanken Fonder reported no remaining Constellation Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
Handelsbanken Fonder sold 9,900 Constellation Pharmaceuticals, Inc. shares in Q3 2021, an estimated $335K.
Handelsbanken Fonder first reported a position in Constellation Pharmaceuticals, Inc. in Q2 2021 and held it in 1 quarter.
Handelsbanken Fonder's Constellation Pharmaceuticals, Inc. position peaked at $335K in Q2 2021.
0 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q3 2021.

Based on Handelsbanken Fonder's 13F filing for Q3 2021, filed 10 Nov 2021.